| 000 | 00907nmm a2200325Ia 4500 | ||
|---|---|---|---|
| 008 | 140908s9999 xx 000 0 und d | ||
| 020 | _a9783034600941, 978-3-0346-0094-1 | ||
| 040 | _aNISER LIBRARY | ||
| 041 | _aEnglish | ||
| 082 |
_a615, _b23 |
||
| 245 | _aDrugs for HER-2-positive Breast Cancer | ||
| 260 |
_aBasel _bSpringer Basel _c2011. |
||
| 500 | _aBiomedical and Life Sciences (Springer-11642) | ||
| 650 | _aAntibodies | ||
| 650 | _aBiomedicine | ||
| 650 | _aCancer Research | ||
| 650 | _aImmunology | ||
| 650 | _aImmunology | ||
| 650 | _aInternal medicine | ||
| 650 | _aInternal Medicine | ||
| 650 | _aMedicine | ||
| 650 | _aMonoclonal antibodies | ||
| 650 | _aOncology | ||
| 650 | _aOncology | ||
| 650 | _aPharmacology/Toxicology | ||
| 650 | _aToxicology | ||
| 700 | _aSibilia, Maria., editor. | ||
| 856 | _uhttp://dx.doi.org/10.1007/978-3-0346-0094-1 | ||
| 942 | _cEB | ||
| 999 |
_c17985 _d17985 |
||